A Study of the Safety, Tolerability, and Pharmacokinetics of SPR720 in Healthy Volunteers
Clinical trial NCT03796910 · COMPLETED
Trial details
- NCT number
- NCT03796910
- Sponsor
- Spero Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-18
- Primary completion
- 2019-09-24
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.